Back to search

Article

MRI-based Prognostic Model in Early-Stage HR+/HER2- Breast Cancer

2026-06-28

Abstract excerpt

<title>Abstract</title> <p>Current genomic assays provide prognostic information and guide chemotherapy decisions in early-stage hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) breast cancer, but limited tissue sampling may incompletely capture tumor heterogeneity. We developed and validated an image-based artificial intelligence (AI) model integrating dynamic contrast-enha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc08554c-d454-5614-84fc-263559476453
DOI
10.21203/rs.3.rs-9772767/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MRI-based Prognostic Model in Early-Stage HR+/HER2- Breast CancerDOI 10.21203/rs.3.rs-9772767/v1
Select a neighboring publication to make it the new centre.